Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTII - Miscellaneous -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (1205)	9/20/2005 11:01:37 AM
From: rkrw	Read Replies (1) \| Respond to of 1296

Got rid of a stale and old program and more importantly the spend associated with it. Yet retained profit sharing in the US. Seems like a great move. Now they have the money to fund viprinex without issuing new shares.

To: zeta1961 who wrote (1205)	9/20/2005 11:32:08 AM
From: John McCarthy	Read Replies (1) \| Respond to of 1296

Hi Zita FWIW (please feel free to comment/disagree/etc) After the $33 million - I stopped reading .... If there are no gotchas/waitfors/exceptions then the $33 million will take us home .... i.e. no future dilution enuf to fully fund ancrod/ Viprinex(TM) the issue remains - (in my mind) can an efficacy HURDLE be reached such that doctors will want to use Viprinex(TM) from a bad memory - per the last P3 USA, trial efficacy was something like this: placebo 33% VS Viprinex 43% I'm not certain anyone really got excited over the above but being an avg joe investor I cannot wrap around it any kind of yardstick or experienced based measurement on the above ... I sense that given the current trial we geared towards both hiking efficacy and reducing the risk of death by a - 1 shot for certain time duration b - patients blood presurre has to be in a certain range or cannot use drug so - its hurry up and wait - and YES - there's Forest in the background with their drug ..... Memantine - still waiting for last years privately run Lupus (dementia) trial to be announced .... and the blurb from Germany about Memantine shutting down binge eating (not sure for how long) - that would be nice to find out it is for real regards, John